CEL-SCI CorpAdd to My Watchlist

CVM:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 0.65
  • 0.07  11.24%
    Today's Change
  • 0.58
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 12/19/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding91 million
Market Cap$59 million
Return on Equity ttm-201.10%
Last DividendCVM:US does not pay a dividend
EPS: Year Actual ttm-0.820
EPS: Year Est. 9/14 ttm-0.445
EPS: Quarterly Actual 6/14 -0.11
EPS: Quarterly Est. 9/14 -0.10
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate57.14
Company Description
CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer.
Net Income$-9 million
Total Assets$11 million
Web Sitewww.cel-sci.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!